These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Changes in urinary composition of calcium oxalate stone formers. Rahman B; Rahman MA Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009 [TBL] [Abstract][Full Text] [Related]
5. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria]. Robert M; Boularan AM; Guiter J; Monnier L Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421 [TBL] [Abstract][Full Text] [Related]
6. [Oxalate loading test for outpatients with calcium oxalate stones]. Kato M Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240 [TBL] [Abstract][Full Text] [Related]
7. Measurement of calcium phosphate crystalluria: influence of pH and osmolality and invariable presence of oxalate. Hallson PC; Rose GA Br J Urol; 1989 Nov; 64(5):458-62. PubMed ID: 2611613 [TBL] [Abstract][Full Text] [Related]
8. Renal excretion of hydrogen ions in stone formers. Marya RK; Dadoo RC; Khurana S; Keshwani RK; Chhabra HL Urol Int; 1979; 34(5):363-8. PubMed ID: 40335 [TBL] [Abstract][Full Text] [Related]
9. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? Kavanagh JP; Laube N J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047 [TBL] [Abstract][Full Text] [Related]
11. A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis. Galán JA; Conte A; Llobera A; Costa-Bauzá A; Grases F Urol Int; 1996; 56(2):79-85. PubMed ID: 8659015 [TBL] [Abstract][Full Text] [Related]
12. Crystalluria and its possible significance. A patient-control study. Abdel-Halim RE Scand J Urol Nephrol; 1993; 27(2):145-9. PubMed ID: 8351464 [TBL] [Abstract][Full Text] [Related]
13. Chemical factors governing the state of saturation towards brushite and whewellite in urine of calcium stone formers. Ackermann D; Baumann JM Urol Res; 1987; 15(2):63-5. PubMed ID: 3590430 [TBL] [Abstract][Full Text] [Related]
14. Crystallization properties in urine from calcium oxalate stone formers. Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098 [TBL] [Abstract][Full Text] [Related]
15. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro? Gjaldbaek JC; Robertson WG Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638 [TBL] [Abstract][Full Text] [Related]
16. Chemical measurement of calcium oxalate crystalluria: results in various causes of calcium urolithiasis. Hallson PC; Rose GA Urol Int; 1990; 45(6):332-5. PubMed ID: 2288049 [TBL] [Abstract][Full Text] [Related]
17. Evening urinary oxalate excretion in stone formers. Banks JG; Sullivan M; Hargreave TB Br J Urol; 1979 Oct; 51(5):349-51. PubMed ID: 533589 [TBL] [Abstract][Full Text] [Related]
18. Crystalluria in idiopathic recurrent calcium urolithiasis. Dependence on stone composition. Herrmann U; Schwille PO Urol Res; 1992; 20(2):157-64. PubMed ID: 1553791 [TBL] [Abstract][Full Text] [Related]
19. Effects of citrate on the different phases of calcium oxalate crystallization. Tiselius HG; Berg C; Fornander AM; Nilsson MA Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807 [TBL] [Abstract][Full Text] [Related]
20. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers. Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]